RECRUITING

Breast Cancer - Navigate - Prospective Cohort

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Chrysalis Initiative (TCI) has with its technology partner Eversana/Intouch developed the BC-Navigate website/application to help guide women through care delivery during breast cancer treatment. TCI a nonprofit, breast cancer education and navigation organization is developing methods to address health inequities in cancer care delivery. TCI and its new academic/clinical partner, The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, propose to apply TCI's developed patient navigation support techniques to enhance knowledge and self-advocacy among a cohort of Black and African American women, and other women of color (WOC), receiving care in Northwestern's breast cancer program. Therefore, the purpose of this study is to apply TCI's patient navigation-and-coaching program and its website/mobile app (Breast Cancer-Navigate) platform to improve timely initiation to patient adjuvant treatment among WOC breast cancer patients and evaluate the feasibility and preliminary efficacy of this approach.

Official Title

Effect of a Navigation Intervention on Care Equity for Women of Color Diagnosed with Breast Cancer: a Feasibility Study

Quick Facts

Study Start:2024-07-10
Study Completion:2025-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06271356

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age and older
  2. * Diagnosed with non-metastatic breast cancer (stages I-III)
  3. * An order placed for a post-operative chemotherapy cycle by a NM clinician
  4. * Not have initiated a recommended post-operative chemotherapy cycle at the time of study enrollment
  5. * Completed surgery for breast cancer
  6. * First-time diagnosis of breast cancer
  7. * Established care at Northwestern Medicine
  8. * English-speaking as the navigation website is not yet available in other languages
  9. * Access to internet on a smart phone or computer/tablet
  10. * Any ethnic background
  11. * We will only consider patients that sign an informed consent form
  1. * Men will be excluded because the navigation website only contains content and resources for women. Men also make up less than 1% of all breast cancer diagnoses and the Breast Cancer-Navigate app/website content was developed for female breast cancer patients.
  2. * Diagnosis of additional, life-threatening condition (e.g., end-stage renal disease, heart failure) which can interfere with timely planned adjuvant chemotherapy treatment for cancer.

Contacts and Locations

Study Contact

Betina Yanez
CONTACT
312-503-5341
betina.yanez@northwestern.edu
Alma Diaz
CONTACT
224-789-9601
alma.diaz@northwestern.edu

Study Locations (Sites)

Northwestern University
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-10
Study Completion Date2025-05

Study Record Updates

Study Start Date2024-07-10
Study Completion Date2025-05

Terms related to this study

Keywords Provided by Researchers

  • eHealth

Additional Relevant MeSH Terms

  • Breast Cancer
  • Quality of Life
  • Chemotherapy